Tonix-SachsConf-1-12-25vFinal5

© 2025 Tonix Pharmaceuticals Holding Corp.Corporate PresentationSachs ConferenceJanuary 12, 2025NASDAQ: TNXPPO6034, January 12, 2025 (Doc 1550)2© 2025 Tonix Pharmaceuticals Holding Corp.Cautionary Note on Forward-Looking Statements Certain statements in this presentation regarding strategic plans, expectations and objectives for future operations or results are “forward-looking statements” as defined by the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as “anticipate,” “believe,” “forecast,” “estimate” and “intend,” among others. These forward-looking statements are based on Tonix’s current expectations and actual results could differ materially. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. These factors include, but are not limited to, the risks related to failure to obtain FDA clearances or approvals and noncompl